Correlation Between Cyteir Therapeutics and Protagenic Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Cyteir Therapeutics and Protagenic Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cyteir Therapeutics and Protagenic Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Cyteir Therapeutics and Protagenic Therapeutics, you can compare the effects of market volatilities on Cyteir Therapeutics and Protagenic Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cyteir Therapeutics with a short position of Protagenic Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cyteir Therapeutics and Protagenic Therapeutics.

Diversification Opportunities for Cyteir Therapeutics and Protagenic Therapeutics

0.0
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Cyteir and Protagenic is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Cyteir Therapeutics and Protagenic Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Protagenic Therapeutics and Cyteir Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cyteir Therapeutics are associated (or correlated) with Protagenic Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Protagenic Therapeutics has no effect on the direction of Cyteir Therapeutics i.e., Cyteir Therapeutics and Protagenic Therapeutics go up and down completely randomly.

Pair Corralation between Cyteir Therapeutics and Protagenic Therapeutics

If you would invest  61.00  in Protagenic Therapeutics on August 26, 2024 and sell it today you would earn a total of  4.00  from holding Protagenic Therapeutics or generate 6.56% return on investment over 90 days.
Time Period3 Months [change]
DirectionFlat 
StrengthInsignificant
Accuracy4.55%
ValuesDaily Returns

Cyteir Therapeutics  vs.  Protagenic Therapeutics

 Performance 
       Timeline  
Cyteir Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Cyteir Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable basic indicators, Cyteir Therapeutics is not utilizing all of its potentials. The current stock price uproar, may contribute to short-horizon losses for the private investors.
Protagenic Therapeutics 

Risk-Adjusted Performance

3 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Protagenic Therapeutics are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. In spite of fairly unfluctuating forward indicators, Protagenic Therapeutics showed solid returns over the last few months and may actually be approaching a breakup point.

Cyteir Therapeutics and Protagenic Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Cyteir Therapeutics and Protagenic Therapeutics

The main advantage of trading using opposite Cyteir Therapeutics and Protagenic Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cyteir Therapeutics position performs unexpectedly, Protagenic Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Protagenic Therapeutics will offset losses from the drop in Protagenic Therapeutics' long position.
The idea behind Cyteir Therapeutics and Protagenic Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the CEOs Directory module to screen CEOs from public companies around the world.

Other Complementary Tools

Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Share Portfolio
Track or share privately all of your investments from the convenience of any device
FinTech Suite
Use AI to screen and filter profitable investment opportunities